Acute coronary syndrome after infliximab infusion

Moeen Abedin, Daniel Scheurich, Sharon C. Reimold, Andreas M. Reimold

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


The TNFα inhibitor infliximab is widely used in the treatment of rheumatoid arthritis and Crohn disease. Mild infusion reactions consisting of low-grade fever, headache, nausea, and fatigue are common, but we describe for the first time the occurrence of an acute coronary syndrome during infliximab administration. This case alerts infusion centers to consider the possibility that chest pain and dyspnea during infliximab infusion can represent a myocardial infarction, even in younger patients without a history of cardiac disease.

Original languageEnglish (US)
Pages (from-to)50-52
Number of pages3
JournalCardiology in Review
Issue number1
StatePublished - Jan 1 2006


  • Biologics
  • Crohn disease
  • Myocardial infarction
  • Rheumatoid arthritis
  • TNFα inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Acute coronary syndrome after infliximab infusion'. Together they form a unique fingerprint.

Cite this